Effect of Thalidomide Plus DOF Regimen in the Treatment of Patients with Stage Ⅳ Gastric Cancer and Its Influence on Expression of Serum sVEGFR-1 and TGF-β1
YANG Yanbing
First-author's address: Dandong First Hospital, Liaoning Province, Dandong 118000, China
杨彦冰①. 沙利度胺叠加DOF方案治疗Ⅳ期胃癌患者的效果及对血清sVEGFR-1、TGF-β1表达的作用[J]. 中国医学创新, 2023, 20(24): 77-80.
YANG Yanbing. Effect of Thalidomide Plus DOF Regimen in the Treatment of Patients with Stage Ⅳ Gastric Cancer and Its Influence on Expression of Serum sVEGFR-1 and TGF-β1. 中国医学创新, 2023, 20(24): 77-80.